Related Experiment Video

Updated: May 31, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

20.8K

Methyl Canthin-6-one-2-carboxylate Inhibits the Activation of the NLRP3 Inflammasome in Synovial Macrophages by

Yuanyuan Chen1,2, Zongying Zhang3, Yuan Yao3

  • 1Graduate School, Dalian Medical University, Dalian 116044, China.

Current Issues in Molecular Biology
|January 24, 2025
PubMed

Insights

A novel compound, Cant, effectively suppresses the NLRP3 inflammasome, a key driver of rheumatoid arthritis (RA). This discovery offers a potential new therapeutic avenue for developing anti-RA drugs by targeting inflammation.

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is an autoimmune disease causing joint inflammation and cartilage damage.
  • Aberrant activation of the NLRP3 inflammasome in synovial macrophages is a critical factor in RA pathogenesis.
  • The NLRP3 inflammasome is recognized as a promising therapeutic target for RA treatment.

Purpose of the Study:

  • To synthesize and evaluate a novel canthin-6-one alkaloid, methyl canthin-6-one-2-carboxylate (Cant).
  • To investigate the effects of Cant on NLRP3 inflammasome activation in macrophages.
  • To explore the potential of Cant as a therapeutic agent for rheumatoid arthritis.

Main Methods:

  • Synthesis of methyl canthin-6-one-2-carboxylate (Cant).
  • Assessment of Cant's effects on pro-inflammatory mediator secretion (IL-1β, IL-6, IL-18, TNF-α, NO, COX2) in macrophages.
  • Analysis of signaling pathways (NF-kB, MAPK, PI3K-AKT) and NLRP3 inflammasome activation (caspase-1, IL-1β cleavage).
  • Investigation of Cant's impact on Nrf2 expression and ROS production.

Main Results:

  • Cant significantly suppressed the transcription and secretion of key pro-inflammatory mediators in a dose-dependent manner.
  • Cant altered the activation of NF-kB, MAPK, and PI3K-AKT signaling pathways.
  • Cant pretreatment reduced LPS/ATP-induced NLRP3 inflammasome activation and IL-1β/caspase-1 cleavage.
  • Cant enhanced Nrf2 expression in macrophages, inhibiting ROS production.

Conclusions:

  • Cant suppresses NLRP3 inflammasome activation, likely by upregulating Nrf2.
  • Cant demonstrates potential as a novel therapeutic candidate for rheumatoid arthritis treatment.
  • Further development of Cant could lead to new anti-RA drugs targeting inflammasome pathways.
Keywords:
NLPR3Nrf2inflammasomeinflammationmacrophagemethyl canthin-6-one-2-carboxylaterheumatoid arthritis

More Related Videos

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

10.6K
Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection07:54

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

46.8K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
945